Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
AFT Pharmaceuticals Ltd. (AU:AFP)
ASX:AFP
RESEARCH TOOLSreports
Holding AU:AFP?
Track your performance easily
AFP Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$2.15 - AU$3.90
Previous CloseAU$2.22
Volume177.00
Average Volume (3M)3.10K
Market Cap
AU$249.32M
Enterprise ValueAU$278.79M
Total Cash (Recent Filing)$7.94M
Total Debt (Recent Filing)$40.51M
Price to Earnings (P/E)21.5
Beta-0.41
Next Earnings
May 26, 2025EPS EstimateN/A
Last Dividend Ex-Date
Jun 19, 2024Dividend Yield0.69%
Share Statistics
EPS (TTM)0.10
Shares OutstandingN/A
10 Day Avg. Volume468
30 Day Avg. Volume3,105
Standard Deviation0.08
R-Squared0.08
Alpha0.00621
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)2.58
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
AFT Pharmaceuticals Ltd. News
PremiumCompany Announcements
AFT Pharmaceuticals Releases Interim Financial Highlights
PremiumCompany Announcements
AFT Pharmaceuticals Unveils Performance Insights
PremiumCompany Announcements
AFT Pharmaceuticals Reports Record Sales Despite Challenges
PremiumCompany Announcements
AFT Pharmaceuticals Strengthens Board with New Director
PremiumCompany Announcements
AFT Pharmaceuticals Sees Increased Investment from ACCPremiumCompany Announcements
AFT Pharmaceuticals Faces First Half Loss, Eyes Recovery
PremiumCompany Announcements
AFT Pharmaceuticals Partners for Global Injectable Launch
PremiumCompany Announcements
AFT Pharmaceuticals Broadens US Market ReachAFP FAQ
What was AFT Pharmaceuticals Ltd.’s price range in the past 12 months?
AFT Pharmaceuticals Ltd. lowest share price was AU$2.15 and its highest was AU$3.90 in the past 12 months.
What is AFT Pharmaceuticals Ltd.’s market cap?
Currently, no data Available
When is AFT Pharmaceuticals Ltd.’s upcoming earnings report date?
AFT Pharmaceuticals Ltd.’s upcoming earnings report date is May 26, 2025 which is in 184 days.
How were AFT Pharmaceuticals Ltd.’s earnings last quarter?
AFT Pharmaceuticals Ltd. released its earnings results on Nov 20, 2024. The company reported -AU$0.018 earnings per share for the quarter, missing the consensus estimate of AU$0.014 by -AU$0.032.
Is AFT Pharmaceuticals Ltd. overvalued?
According to Wall Street analysts AFT Pharmaceuticals Ltd.’s price is currently Overvalued.
Does AFT Pharmaceuticals Ltd. pay dividends?
AFT Pharmaceuticals Ltd. pays a Annually dividend of AU$0.01 which represents an annual dividend yield of 0.69%. See more information on AFT Pharmaceuticals Ltd. dividends here
What is AFT Pharmaceuticals Ltd.’s EPS estimate?
AFT Pharmaceuticals Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does AFT Pharmaceuticals Ltd. have?
AFT Pharmaceuticals Ltd. has 104,866,260 shares outstanding.
What happened to AFT Pharmaceuticals Ltd.’s price movement after its last earnings report?
AFT Pharmaceuticals Ltd. reported an EPS of -AU$0.018 in its last earnings report, missing expectations of AU$0.014. Following the earnings report the stock price went up 3.256%.
Which hedge fund is a major shareholder of AFT Pharmaceuticals Ltd.?
Currently, no hedge funds are holding shares in AU:AFP
---
AFT Pharmaceuticals Ltd. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:AFP Sentiment 100%
Sector Average 72%
Sector Average 72%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-32.35%
12-Months-Change
Fundamentals
Return on Equity
14.85%
Trailing 12-Months
Asset Growth
-8.30%
Trailing 12-Months
Company Description
AFT Pharmaceuticals Ltd.
AFT Pharmaceuticals Ltd is a pharmaceutical distributor and developer of pharmaceutical intellectual property. Some of the products of the organization are Aqueous cream, Calci-tab, Coco-scalp, Cromo-fresh, Crystaderm, Crytawash, Ellgy plus, Emulsifying ointment, and others. The group has four operating segments based on geographical location being, Australia, New Zealand, Southeast Asia and the Rest of the world. It generates the majority of the revenue from Australia which includes the sales and distribution activity relating to the Australian market.
---
AFP Stock 12 Month Forecast
Average Price Target
―Technical Analysis
---